Glucophage

Glucophage is a brand-name medication containing the active ingredient metformin hydrochloride, supplied in oral tablet form (strength varies) and marketed in the European Union. It belongs to the biguanide class of antidiabetic drugs and is prescribed by healthcare professionals for the management of blood glucose levels in adults with type 2 diabetes mellitus. Glucophage is available only with a prescription and is commonly used as a first-line therapy.

Glucophage is indicated for the treatment of type 2 diabetes mellitus and is used as part of a comprehensive diabetes management plan.

- Improves glycemic control when combined with diet and exercise. - Can be used as monotherapy in patients with newly diagnosed type 2 diabetes. - May be added to insulin or other oral antidiabetic agents when additional glucose lowering is required. - Occasionally prescribed off‑label for polycystic ovary syndrome under specialist supervision. - Used in renal‑adjusted dosing for patients with mild to moderate kidney impairment, following clinical guidelines.

Side effects of Glucophage vary in frequency; most are mild and transient, while rare reactions may require medical attention.

Common: - Gastrointestinal upset such as nausea, abdominal discomfort, or diarrhea. - Metallic taste in the mouth. - Decreased appetite or mild weight loss. - Vitamin B12 deficiency with long‑term use. - Elevated liver enzymes.

Serious: - Lactic acidosis, a rare but potentially life‑threatening condition. - Severe skin reactions, including Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Persistent or worsening kidney dysfunction.

Before starting Glucophage, healthcare providers assess several clinical factors to minimize risks and ensure safe use.

- Assess renal function; contraindicated in severe renal impairment. - Evaluate liver disease status, as hepatic dysfunction can increase lactic acidosis risk. - Review any history of alcohol abuse, which may potentiate metabolic complications. - Monitor for signs of hypoglycemia when used with insulin or sulfonylureas. - Adjust dose in elderly patients due to altered pharmacokinetics. - Consider vitamin B12 levels during long‑term therapy. - Discontinue before any iodinated contrast imaging that may affect kidney function.

Glucophage can interact with other medicines, affecting its efficacy or increasing the risk of adverse events.

Avoid: - Iodinated contrast agents used for radiographic studies; may precipitate acute kidney injury. - Cimetidine, which can raise metformin plasma concentrations. - Certain antivirals such as dolutegravir that may increase metformin exposure.

Use with caution: - Insulin or sulfonylureas, as combined therapy raises hypoglycemia risk. - Diuretics that may affect renal clearance of metformin. - ACE inhibitors or ARBs in patients with compromised renal function.